# Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment

> **NCT03431961** · NA · UNKNOWN · sponsor: **Gail Gauvreau** · enrollment: 20 (estimated)

## Conditions studied

- Allergic Asthma

## Interventions

- **DRUG:** Triamcinolone Acetonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03431961
- **Lead sponsor:** Gail Gauvreau
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-07
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431961, "Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03431961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*